within Pharmacolibrary.Drugs.ATC.M;

model M03AA02
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 2.1666666666666667e-05,
    adminDuration  = 600,
    adminMass      = 25 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 8.999999999999999e-05,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.00022,
    k12             = 0.24,
    k21             = 0.24
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>M03AA02</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Tubocurarine is a non-depolarizing skeletal muscle relaxant, historically used adjunctively in anesthesia to produce muscle relaxation during surgery or mechanical ventilation. It acts by blocking nicotinic acetylcholine receptors at the neuromuscular junction. Its use has largely been discontinued due to side effects and the development of newer, safer alternatives.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult surgical patients, following intravenous administration.</p><h4>References</h4><ol><li><p>Meijer, DK, et al., &amp; Scaf, AH (1979). Comparative pharmacokinetics of d-tubocurarine and metocurine in man. <i>Anesthesiology</i> 51(5) 402–407. DOI:<a href=&quot;https://doi.org/10.1097/00000542-197911000-00007&quot;>10.1097/00000542-197911000-00007</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/496054/&quot;>https://pubmed.ncbi.nlm.nih.gov/496054</a></p></li><li><p>Miller, RD, et al., &amp; Sohn, YJ (1977). The pharmacokinetics of d-tubocurarine in man with and without renal failure. <i>The Journal of pharmacology and experimental therapeutics</i> 202(1) 1–7. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/195035/&quot;>https://pubmed.ncbi.nlm.nih.gov/195035</a></p></li><li><p>Ham, J, et al., &amp; Roderick, LL (1978). Pharmacokinetics and pharmacodynamics of d-tubocurarine during hypothermia in the cat. <i>Anesthesiology</i> 49(5) 324–329. DOI:<a href=&quot;https://doi.org/10.1097/00000542-197811000-00005&quot;>10.1097/00000542-197811000-00005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/736287/&quot;>https://pubmed.ncbi.nlm.nih.gov/736287</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end M03AA02;
